Universe Pharmaceuticals annual capital expenditures (capex)
2019
2020
2021
2022
2023
2024
2025
Universe Pharmaceuticals Capital Expenditures (CapEx) Growth & History (UPC)
Universe Pharmaceuticals's capital expenditures (capex) was $266.8M for fiscal 2025.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $266.8M | $58.5M | +28.06% |
| 2024 | 2024-09-30 | $208.3M | $208.3M | +471543.01% |
| 2023 | 2023-09-30 | $44,169 | −$49,534 | −52.86% |
| 2022 | 2022-09-30 | $93,703 | −$350,802 | −78.92% |
| 2021 | 2021-09-30 | $444,505 | $392,707 | +758.15% |
| 2020 | 2020-09-30 | $51,798 | −$34,526 | −40.00% |
| 2019 | 2019-09-30 | $86,324 | — | — |
Universe Pharmaceuticals capital expenditures (capex) trends
Over the last five fiscal years, Universe Pharmaceuticals's capital expenditures (capex) increased from $51,798 to $266.8M, a change of $266.7M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals source filings ↗